نتایج جستجو برای: nvp

تعداد نتایج: 1232  

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008
Ferdinand W N M Wit Anouk M Kesselring Luuk Gras Clemens Richter Marchina E van der Ende Kees Brinkman Joep M A Lange Frank de Wolf Peter Reiss

BACKGROUND Recommendations that nevirapine (NVP) should be avoided in female individuals with CD4 cell counts >250 cells/microL and in male individuals with CD4 cell counts >400 cells/microL are based on findings in treatment-naive patients. It is unclear whether these guidelines also apply to treatment-experienced patients switching to NVP-based combination therapy. METHODS Patients in the A...

2014
Bhagyashree R Dalvi Shilpa M Velhal Atmaram B Bandivadekar Absar Ahmad Padma V Devarajan

Results GMS nVP auNPs with > 75% entrapment efficiency & < 300nm particle size were prepared and surface modified nanoparticles showed >85% binding to the ligand. In cytotoxicity study nanoformulations showed higher cell viability at all time points as compared to NVP. Cell uptake study revealed higher uptake of nanoparticles as compared to NVP only. In vitro anti HIV assay of surface modified ...

Journal: :PLoS ONE 2009
Anitha Moorthy Amita Gupta Ramesh Bhosale Srikanth Tripathy Jayagowri Sastry Smita Kulkarni Madhuri Thakar Renu Bharadwaj Anju Kagal Arvind V. Bhore Sandesh Patil Vandana Kulkarni Varadharajan Venkataramani Usha Balasubramaniam Nishi Suryavanshi Carrie Ziemniak Nikhil Gupte Robert Bollinger Deborah Persaud

BACKGROUND Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV transmission. We assessed NVP-resistance in Indian infants enrolled in the "six-week extended-dose nevirapine" (SWEN) trial who received single-dose NVP (SD-NVP) or SWEN for prevention of breast-milk HIV transmission but who also acquired subtype C HIV infection during the first year of li...

2013
Caroline Maltepe Gideon Koren

Objectives. To determine whether the initiation of treatment (preemptive treatment) before the symptoms of nausea and vomiting of pregnancy (NVP) versus when the symptoms begin can improve the outcome in patients at a high risk for recurrence of severe NVP. Study Design. Prospective, randomized controlled trial. Results. Preemptive therapy conferred a significant reduction in HG as compared to ...

Journal: :International journal of epidemiology 2007
Elise Arrivé Marie-Louise Newell Didier K Ekouevi Marie-Laure Chaix Rodolphe Thiebaut Bernard Masquelier Valériane Leroy Philippe Van de Perre Christine Rouzioux François Dabis

BACKGROUND Single-dose nevirapine (NVP) is the main option for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in countries with limited resources. However, the use of single-dose NVP results in HIV-1 viral resistance which could compromise the success of subsequent treatment of mother and child with antiretroviral combinations that include non-nucleosidic-reverse-transcriptase ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Margaret M Centenera Joanna L Gillis Adrienne R Hanson Shalini Jindal Renea A Taylor Gail P Risbridger Peter D Sutherland Howard I Scher Ganesh V Raj Karen E Knudsen Trina Yeadon Wayne D Tilley Lisa M Butler

PURPOSE Targeting Hsp90 has significant potential as a treatment for prostate cancer, but prototypical agents such as 17-allylamino-17 demethoxygeldanamycin (17-AAG) have been ineffective in clinical trials. Recently, a phase I study aimed at defining a biologically active dose reported the first response to an Hsp90 inhibitor in a patient with prostate cancer, which supports the development of...

2014
Yu Wang Qi Yu Xin He Todd Romigh Jessica Altemus Charis Eng

NVP-BEZ235 is a newly developed dual PI3K/mTOR inhibitor, being tested in multiple clinical trials, including breast cancer. NVP-BEZ235 selectively induces cell growth inhibition in a subset, but not all, breast cancer cell lines. However, it remains a challenge to distinguish between sensitive and resistant tumors, particularly in the pretreatment setting. Here, we used ten breast cancer cell ...

2011
Kevin Murray

Background: To examine the association between the risk of nausea and vomiting of pregnancy (NVP) with the ABO blood groups. Method: One hundred and eighteen women who were currently or previously pregnant volunteered for a study on NVP. All women completed a questionnaire assessing the severity of NVP and their general condition. Their obstetrical and physical characteristics as well as their ...

2016
XIAOYU YANG BINGXUAN NIU LIBO WANG MEILING CHEN XIAOCHUN KANG LUONAN WANG YINGHUA JI JIATENG ZHONG

Phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) signaling pathway performs a central role in tumorigenesis and is constitutively activated in many malignancies. As a novel dual PI3K/mTOR inhibitor currently undergoing evaluation in a phase I/II clinical trial, NVP-BEZ235 indicates a significant antitumor efficacy in diverse solid tumors, including colorectal cancer (CR...

Journal: :Antimicrobial agents and chemotherapy 2015
John M Cortez Rafaela Quintero John A Moss Martin Beliveau Thomas J Smith Marc M Baum

Mother-to-child transmission (MTCT) of HIV-1 remains a global health problem. The World Health Organization (WHO) recommendations advise the administration of a once-daily, oral, prophylactic regimen of the nonnucleoside reverse transcriptase inhibitor nevirapine (NVP) from birth until 4 to 6 weeks of age for infants born to HIV-infected mothers in regions without access to safe and nutritional...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید